SMART START: RITUXIMAB, LENALIDOMIDE, AND IBRUTINIB ALONE PRIOR TO COMBINATION WITH CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA. (12th June 2019) - Westin, J.R.; Nastoupil, L.; Hagemeister, F.; Fayad, L.; Young, K.; McDonnell, T.; Chuang, H.; Ahmed, S.; Nair, R.; Steiner, R.; Lee, H.; Rodriguez, M.; et al.